http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 23 Sep 2025 09:20:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html <p align="justify"><strong>WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”)</strong>, a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), has engaged Lytham Partners to lead a strategic investor relations and shareholder communication program.</p> <p align="justify">For more than 20 years, Lytham Partners has been one of the country&apos;s leading investor relations firms, having created one of the industry&apos;s largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with http://www.streetinsider.com/Press+Releases/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html Tue, 23 Sep 2025 09:20:00 -0400 BFRI BFRIW O.52535366 http://www.streetinsider.com/Press+Releases/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html <p align="justify"><strong>WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”)</strong>, a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), has engaged Lytham Partners to lead a strategic investor relations and shareholder communication program.</p> <p align="justify">For more than 20 years, Lytham Partners has been one of the country&apos;s leading investor relations firms, having created one of the industry&apos;s largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with http://www.streetinsider.com/Press+Releases/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html Tue, 23 Sep 2025 09:20:00 -0400 BFRI BFRIW O.52535366 http://www.streetinsider.com/Press+Releases/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html <p align="justify"><strong>WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”)</strong>, a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), has engaged Lytham Partners to lead a strategic investor relations and shareholder communication program.</p> <p align="justify">For more than 20 years, Lytham Partners has been one of the country&apos;s leading investor relations firms, having created one of the industry&apos;s largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with http://www.streetinsider.com/Press+Releases/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html Tue, 23 Sep 2025 09:20:00 -0400 BFRI BFRIW O.52535366 http://www.streetinsider.com/Globe+Newswire/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html <p align="justify"><strong>WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”)</strong>, a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), has engaged Lytham Partners to lead a strategic investor relations and shareholder communication program.</p> <p align="justify">For more than 20 years, Lytham Partners has been one of the country&apos;s leading investor relations firms, having created one of the industry&apos;s largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with http://www.streetinsider.com/Globe+Newswire/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html Tue, 23 Sep 2025 09:20:00 -0400 BFRI BFRIW O.52535366 http://www.streetinsider.com/Globe+Newswire/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html <p align="justify"><strong>WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”)</strong>, a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), has engaged Lytham Partners to lead a strategic investor relations and shareholder communication program.</p> <p align="justify">For more than 20 years, Lytham Partners has been one of the country&apos;s leading investor relations firms, having created one of the industry&apos;s largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with http://www.streetinsider.com/Globe+Newswire/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html Tue, 23 Sep 2025 09:20:00 -0400 BFRI BFRIW O.52535366 http://www.streetinsider.com/Globe+Newswire/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html <p align="justify"><strong>WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”)</strong>, a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), has engaged Lytham Partners to lead a strategic investor relations and shareholder communication program.</p> <p align="justify">For more than 20 years, Lytham Partners has been one of the country&apos;s leading investor relations firms, having created one of the industry&apos;s largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with http://www.streetinsider.com/Globe+Newswire/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html Tue, 23 Sep 2025 09:20:00 -0400 BFRI BFRIW O.52535366